Initial Clinical Evaluation
Each patient undergoes a detailed assessment including cardiovascular risk profiling, metabolic parameters, current medications, and a thorough review of dietary and lifestyle patterns. Equal importance is given to understanding how existing conditions such as hypertension, diabetes, or high cholesterol are interacting with weight.
Integrated Treatment Strategy
Management plans are designed with a clear focus on overlap between obesity and cardiovascular disease. Treatment is individualised to ensure that weight management supports, and does not conflict with, existing cardiac care. Where required, medical therapy is introduced or adjusted to achieve better control of blood pressure, lipid levels, and metabolic health while facilitating safe weight reduction.
Medication Optimisation and Obesity Management
A key component of care is the thoughtful optimisation of medications. This includes rationalising existing prescriptions, minimising drug-related weight effects where possible, and introducing evidence-based medical management for obesity when indicated. The goal is to create synergy between weight reduction and improved control of hypertension, cholesterol, and cardiac risk, rather than treating each condition in isolation.
